NCT06069167

Brief Summary

Bowel urgency is commonly defined as the sudden need to rush to the bathroom to empty one's bowel. In the field of inflammatory bowel disease (IBD) (including Crohn's disease (CD) and ulcerative colitis (UC)), bowel urgency is part of the top five research priorities for future IBD nursing research, and it is a symptom that patients consider to be most important when prioritizing their disease control. Urgency is a patient-reported outcome associated with compromised quality of life and future risk of hospitalizations, corticosteroids, and colectomy in patients with UC. A meta-analysis of 321 studies examining bowel urgency revealed that only one-third of these clinical studies clearly defined the concept of bowel urgency. Definition of bowel urgency was heterogeneous as 14 different definitions were identified. In most of these studies, non-validated questionnaires were used. They are based on subjective responses of the patients, and they could determine evaluation bias. These data emphasize the lack of standardization in bowel urgency assessment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 1, 2023

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 5, 2023

Completed
7 days until next milestone

Study Start

First participant enrolled

October 12, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 22, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 22, 2024

Completed
Last Updated

March 26, 2024

Status Verified

March 1, 2024

Enrollment Period

5 months

First QC Date

October 1, 2023

Last Update Submit

March 22, 2024

Conditions

Keywords

Bowel urgencyURGENT indexIBDUNRS (Urgency Numeric Rating Scale)GVE (Global Visual Evaluation)

Outcome Measures

Primary Outcomes (1)

  • Prevalence of bowel urgency in a cohort of patients with inflammatory bowel disease

    Inability to defer defecation for more than 15 minutes in patients with inflammatory bowel disease

    Through study completion, an average of 12 months

Secondary Outcomes (7)

  • Prevalence of bowel urgency in a cohort of Crohn's disease patients

    Through study completion, an average of 12 months

  • Prevalence of bowel urgency in a cohort of ulcerative colitis patients

    Through study completion, an average of 12 months

  • Development of the URGENT index (i.e. inflammatory bowel disease-specific bowel urgency index)

    Through study completion, an average of 12 months

  • To identify IBD-related risk factors associated with an increased risk of bowel urgency

    Through study completion, an average of 12 months

  • Correlation between the URGENT index and the Urgency Numeric Rating Scale

    Through study completion, an average of 12 months

  • +2 more secondary outcomes

Interventions

Data will be extracted from the patient's medical record and patients will be interviewed to collect data specific to the research

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Inflammatory bowel disease patients

You may qualify if:

  • Male or female, aged at least 18 years old
  • Diagnosis of inflammatory bowel disease according to the European Crohn´s and Colitis Organisation criteria for at least 3 months
  • Person who has received full information about the organization of the research and who has not objected to his or her participation and to the use of his or her data
  • Person affiliated to or beneficiary of a social security plan

You may not qualify if:

  • Person unable to comply with study procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institut des MICI

Neuilly-sur-Seine, 92200, France

Location

MeSH Terms

Conditions

Inflammatory Bowel DiseasesCrohn DiseaseColitis, Ulcerative

Condition Hierarchy (Ancestors)

GastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal DiseasesColitisColonic Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 1, 2023

First Posted

October 5, 2023

Study Start

October 12, 2023

Primary Completion

March 22, 2024

Study Completion

March 22, 2024

Last Updated

March 26, 2024

Record last verified: 2024-03

Locations